From American Association of Health
FDA Reports 1 death per month related to Gardasil

The American Association for Health Freedom (AAHF) believes that the right of the consumer to choose and the practitioner to practice relates to all health care choices, including vaccination. AAHF is an advocate for opt-in (as opposed to mandatory) policies for vaccines, particularly the HPV vaccine.

As the news article below details, Gardasil, the vaccine created and marketed by Merck, is causing one death per month and numerous, serious reactions according to a recent FDA report.

Despite this information Merck continues to promote Gardasil and push to make the vaccine mandatory in all states through an intense lobbying effort. Unfortunately, many states rushed to add Gardisal to the ever-growing list of mandatory vaccines last year. Almost every state introduced legislation in 2007 regarding the HPV vaccine. Our 2007 Government Affairs Annual Report addresses this topic under a special section entitled “Hot Issue”. (Note to members, you will be emailed your copy of the report this week!)

Our CAM-V initiative (Campaign Against Mandatory Vaccinations) is headed by renowned vaccination expert, Dr. Sherri Tenpenny and is lead by our state chapters. If you’re interested in getting involved, please contact Director of State Chapters, Sara Donlon at sara@healthfreedom.net or 614.888.7351.

Controversial HPV Vaccine Causing One Death Per Month: FDA Report 140 "serious" adverse reactions, including 27 "life threatening" cases, 10 spontaneous abortions, and 6 cases of the debilitating Guillain-Barre Syndrome reported since January 2008

By Peter J. Smith

WASHINGTON, D.C., July 3, 2008 (LifeSiteNews.com) - One death per month is the average loss of life associated with the cervical cancer vaccine Gardasil according to an FDA report obtained by a government watchdog agency.

Merck, the makers of Gardasil, are poised to make profits in the billions from the vaccine, which protects against some cancer-causing forms of the sexually transmitted human papilloma virus (HPV), but the pharmaceutical giant has come under heavy criticism for fast-tracking the drug onto the market without adequate testing in order to beat out its rivals...

The full text of the story is available at:

http://www.lifesitenews.com/ldn/2008/jul/08070316.html